These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8528701)
1. Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord. Pugh G; Abood ME; Welch SP Brain Res; 1995 Aug; 689(1):157-8. PubMed ID: 8528701 [TBL] [Abstract][Full Text] [Related]
2. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse. Tseng LF; Collins KA; Kampine JP Eur J Pharmacol; 1994 Jun; 258(1-2):R1-3. PubMed ID: 7925585 [TBL] [Abstract][Full Text] [Related]
3. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids. Miaskowski C; Levine JD Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770 [TBL] [Abstract][Full Text] [Related]
4. Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a kappa-opioid receptor. Chien CC; Brown G; Pan YX; Pasternak GW Eur J Pharmacol; 1994 Mar; 253(3):R7-8. PubMed ID: 8200413 [TBL] [Abstract][Full Text] [Related]
5. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice. Smith PB; Welch SP; Martin BR J Pharmacol Exp Ther; 1994 Mar; 268(3):1381-7. PubMed ID: 8138952 [TBL] [Abstract][Full Text] [Related]
6. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord. Narita M; Mizoguchi H; Kampine JP; Tseng LF Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295 [TBL] [Abstract][Full Text] [Related]
7. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265 [TBL] [Abstract][Full Text] [Related]
8. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice. Welch SP J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455 [TBL] [Abstract][Full Text] [Related]
9. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor. Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351 [TBL] [Abstract][Full Text] [Related]
11. Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists. Miaskowski C; Sutters KA; Taiwo YO; Levine JD Pain; 1992 Apr; 49(1):137-144. PubMed ID: 1317544 [TBL] [Abstract][Full Text] [Related]
12. Antisense oligodeoxynucleotide to a delta-opioid receptor blocks the antinociception induced by cold water swimming. Mizoguchi H; Narita M; Nagase H; Tseng LF Regul Pept; 1995 Oct; 59(2):255-9. PubMed ID: 8584762 [TBL] [Abstract][Full Text] [Related]
13. Antisense oligodeoxynucleotide to a delta-opioid receptor given intrathecally blocks i.c.v. administered beta-endorphin-induced antinociception in the mouse. Tseng LF; Collins KA Life Sci; 1994; 55(7):PL127-31. PubMed ID: 8041224 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of antisense oligodeoxynucleotides directed against g(zalpha) and g(oalpha) on antinociception produced by spinal opioid and alpha(2) adrenergic receptor agonists. Karim F; Roerig SC Pain; 2000 Aug; 87(2):181-191. PubMed ID: 10924811 [TBL] [Abstract][Full Text] [Related]
15. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
16. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse. Suh HW; Chung KM; Kim YH; Huh SO; Song DK Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481 [TBL] [Abstract][Full Text] [Related]
17. Distinct antinociceptive actions mediated by different opioid receptors in the region of lamina I and laminae III-V of the dorsal horn of the rat. Hope PJ; Fleetwood-Walker SM; Mitchell R Br J Pharmacol; 1990 Oct; 101(2):477-83. PubMed ID: 2175238 [TBL] [Abstract][Full Text] [Related]
18. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350 [TBL] [Abstract][Full Text] [Related]
19. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo. Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. Machelska H; Labuz D; Przewłocki R; Przewłocka B J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]